C4 Therapeutics shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in C4 Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including C4 Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in C4 Therapeutics by Charles Schwab Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.4M | 253k | 5.65 |
| 2023-09-30 | $462k | 248k | 1.86 |
| 2023-06-30 | $635k | 231k | 2.75 |
| 2023-03-31 | $995k | 317k | 3.14 |
| 2022-12-31 | $2.1M | 357k | 5.90 |
| 2022-09-30 | $3.1M | 352k | 8.77 |
| 2022-06-30 | $2.1M | 273k | 7.54 |
| 2022-03-31 | $6.6M | 273k | 24.26 |
| 2021-12-31 | $8.5M | 265k | 32.20 |
| 2021-09-30 | $12M | 261k | 44.68 |
| 2021-06-30 | $5.3M | 141k | 37.85 |
| 2021-03-31 | $2.6M | 70k | 37.00 |
| 2020-12-31 | $2.2M | 67k | 33.14 |
More positions owned by Charles Schwab Investment Management
Home Depot (HD)
View all positions for Charles Schwab Investment Management